Ischaemic heart disease continues to be a major global public health challenge, highlighting the need for targeted interventions addressing modifiable risk factors.
Persistent IHD burden warrants sustained prevention efforts; leaves open optimal global strategies.
Our results suggested that IHD remains a major public health challenge worldwide. More effective and targeted strategies aimed at implementing cost-effective interventions and addressing modifiable risk factors are urgently needed, particularly in geographies with high or increasing burden.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: